Review article: Cerebrospinal fluid in human African trypanosomiasis: A key to diagnosis, therapeutic decision and post-treatment follow-up

Tropical Medicine and International Health

Volumn 10, Issue 5, 2005, Pages 395-403

  Lejon, Veerle ^a   Buscher P ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Central nervous system; Cerebrospinal fluid; Diagnosis; Diagnostic criteria; Human African trypanosomiasis; Review; Treatment

Indexed keywords

ANTITRYPANOSOMAL AGENT; ARSENIC DERIVATIVE; DB 289; EFLORNITHINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; SURAMIN; UNCLASSIFIED DRUG;

DISEASE TREATMENT; TRYPANOSOMIASIS;

AFRICAN TRYPANOSOMIASIS; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DRUG FATALITY; DRUG INDUCED DISEASE; FOLLOW UP; HUMAN; MEDICAL DECISION MAKING; REVIEW; TREATMENT PLANNING;

ANIMALS; CENTRAL NERVOUS SYSTEM INFECTIONS; DECISION MAKING; HUMANS; IMMUNOGLOBULINS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 19044368165     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01403.x     Document Type: Review

References (78)

1. Apted FIC (1970a) Clinical manifestations and diagnosis of sleeping sickness. In: The African Trypanosomiases (ed. Mulligan HW) George Allen and Unwin Ltd, London, pp. 661-683.
2. Apted FIC (1970b) The epidemiology of Rhodesian Sleeping Sickness. In: The African Trypanosomiasis (ed. Mulligan HW) George Allen and Unwin Ltd, London, pp. 645-660.
3. Ayed Z, Brindel I, Bouteille B et al. (1997) Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. American Journal of Tropical Medicine and Hygiene 57, 1-6.
4. Bisser S, Bouteille B, Sarda J et al. (1997) Apport des examens biochimiques dans le diagnostic de la phase nerveuse de la trypanosomose humaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 90, 321-326.
5. Bisser S, Ayed Z, Bouteille B et al. (2000) Central nervous system involvement in African trypanosomiasis: presence of anti-galactocerebroside antibodies in patients' cerebrospinal fluid. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 225-226.
6. Bisser S, Lejon V, Preux PM et al. (2002) Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. Journal of the Neurological Sciences 193, 127-135.
7. Boa YF, Traore MA, Doua F et al. (1988) Les différents tableaux cliniques actuels de la trypanosomiase humaine Africaine à T. b. gambiense. Analyse de 300 dossiers du foyer de Daloa, Côte-d'Ivoire. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 427-444.
8. Broden A & Rodhain J (1908) Le liquide cérébro-spinal dans la trypanosomiase humaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 1, 496-499.
9. Burri C & Brun R (2003) Human African trypanosomiasis. In: Manson's Tropical Diseases 21st edn (eds Cook GC & Zumla AI) Elsevier, Edinburgh, pp. 1303-1323.
10. Burri C, Nkunku S, Merolle A et al. (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. The Lancet 355, 1419-1425.
11. Büscher P & Lejon V (2004) Diagnosis of human African trypanosomiasis. In: Trypanosomiasis Textbook (eds Maudlin I, Holmes P & Miles MA) CABI Publishing, Oxfordshire, pp. 203-218.
12. Büscher P, Lejon V, Magnus E & Van Meirvenne N (1999) Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients. Acta Tropica 73, 11-20,
13. Cattand P, Miézan BT & de Raadt P (1988) Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bulletin of the World Health Organization 66, 83-86.
14. Courtioux B, Boda C, Nangouma A et al. (2003) A propos d'un nouveau test pour le diagnostic de terrain de la phase nerveuse de la trypanosomose humaine africaine. Medicine Tropicale 63, 327.
15. Doua F, Miézan TW, Sanon SR, Boa YF & Baltz T (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. American Journal of Tropical Medicine and Hygiene 55, 586-588.
16. Duggan AJ & Hutchinson MP (1966) Sleeping sickness in europeans: a review of 109 cases. Journal of Tropical Medicine and Hygiene 69, 124-131.
17. Dumas M & Bisser S (1999) Clinical aspects of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds Dumas M, Bouteille B & Buguet A) Springer, Paris, pp. 215-233.
18. Dumas M & Girard PL (1978) Human African trypanosomiasis (Sleeping sickness). In: Handbook of Clinical Neurology, Vol 35: Infections of the Nervous System. Part III (eds Vinken PJ & Bruyn GW) North-Holland Publishing Co., Amsterdam, pp. 67-83.
19. Edan G (1979) Signes cliniques et biologiques des trypanosomiases à T. gambiense vues au stade d'atteinte méningo- encéphalitique. Médecine Tropicale 39, 499-507.
20. Greenwood BM & Whittle HC (1973) Cerebrospinal-fluid IgM in patients with sleeping-sickness. The Lancet 2, 525-527.
21. Greenwood BM & Whittle HC (1980) The pathogenesis of sleeping sickness. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 716-725.
22. Greenwood BM, Whittle HC, Oduloju KO & Dourmashkin RR (1976) Lymphocytic infiltration of the brain in sleeping sickness. British Medical Journal 2, 1291-1292.
23. Jamonneau V, Solano P, Garcia A et al. (2003) Stage determination and therapeutic decision in human African trypanosomiasis: value of PCR and IgM quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire. Tropical Medicine and International Health 8, 589-594.
24. Jauberteau M-O, Bisser S, Ayed Z et al. (1994) Détection d'autoanticorps anti-galactocérébrosides au cours de la trypanosomose humaine africaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 87, 333-336.
25. Kennedy PGE (2004) Human African trypanosomiasis of the CNS: current issues and challenges. Journal of Clinical Investigation 113, 496-504.
26. Kirchhoff LV (1998) Use of a PCR assay for diagnosing African trypanosomiasis of the CNS: a case report. Central African Journal of Medicine 44, 134-136.
27. Knobloch J, Tischendorf F, König J & Mehlitz D (1984) Evaluation of immunoassays for diagnosis and management of sleeping sickness in Liberia. Tropenmedizin und Parasitologie 35, 137-140.
28. Kristensson K & Bentivoglio M (1999) Pathology of African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds Dumas M, Bouteille B & Buguet A) Springer, Paris, pp. 157-181.
29. Kyambadde JW, Enyaru JCK, Matovu E, Odiit M & Carasco JF (2000) Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bulletin of the World Health Organization 78, 119-124.
30. Lambert PH, Berney M & Kazyumba G (1981) Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. Journal of Clinical Investigation 67, 77-85.
31. Laveran A & Mesnil F (1912) Trypanosomiase humaine ou maladie du sommeil. In: Trypanosomes et Trypanosomiases, 2nd edn, Masson et Cie, Paris, pp. 673-795.
32. Legros D, Erphas O, Priotto G et al. (2001). Pentamidine versus Mélarsoprol dans le traitement des stades neurologiques précoces de trypanosomiase à T.b. gambiense en Ouganda. Marseille, France. Journées du Pharo, 6-8 septembre 2001.
33. Legros D, Ollivier G, Gastellu-Etchegorry M et al. (2002) Treatment of human African trypanosomiasis - present situation and needs for research and development. Lancet Infectious Diseases 2, 437-440.
34. Lejon V, Büscher P, Magnus E et al. (1998) A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Acta Tropica 69, 151-164.
35. Lejon V, Rosengren LE, Büscher P, Karlsson JE & Sema NH (1999) Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infeaed patients. American Journal of Tropical Medicine and Hygiene 60, 94-98.
36. Lejon V, Lardon J, Kenis G et al. (2002a) Interleukin-6, IL-8 and IL-10 in serum and CSF of T.b. gambiense sleeping sickness patients before and after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 329-333.
37. Lejon V, Legros D, Richer M et al. (2002b) IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Tropical Medicine and International Health 7, 685-692.
38. Lejon V, Reiber H, Legros D et al. (2003a) Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. Journal of Infectious Diseases 187, 1475-1483.
39. Lejon V, Sindic C, Van Antwerpen M-P et al. (2003b) Human African trypanosomiasis: quantitative and qualitative assessment of intrathecal immune response. European Journal of Neurology 10, 711-719.
40. Lejon V, Legros D, Savignoni A et al. (2003c) Neuroinflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with Pentamidine. Journal of Neuroimmunology 144, 132-138.
41. Lemesre JL, Noireau F, Makoundou ML, Louembet MT & Frézil J-L (1988) Apport des techniques sérologiques dans l'analyse du liquide céphalo-rachidien de patients congolais atteints de la maladie du sommeil. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 506-510.
42. Lourie EM (1942) Treatment of sleeping sickness in Sierra Leone. Tropical Medicine and Parasitology 36, 113-131.
43. Lucasse C (1964) Fluorescent antibody test as applied to cerebrospinal fluid in human sleeping sickness. Bulletin de la Société de Pathologie Exotique et de ses Filiales 57, 283-292.
44. Lumsden WHR, Kimber CD, Evans DA & Doig SJ (1979) Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 312-317.
45. MacLean L, Odiit M & Sternberg JM (2001) Nitric oxide and cytokine synthesis in human African trypanosomiasis. Journal of Infectious Diseases 184, 1086-1090.
46. Magnus E, Vervoort T & Van Meirvenne N (1978) A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b. gambiense trypanosomiasis. Annales de la Société Belge de Médecine Tropicale 58, 169-176.
47. Mattern P (1967) Etude du taux de gamma-globuline dans le liquide cephalo-rachidien. Septième Conférence technique O.C.C.G.E., Mars 1967, 1053-1056.
48. Mattern P (1968) Etat actuel et résultats des techniques immunologiques utilisées à l'Institut Pasteur de Dakar pour le diagnostic et l'étude de la trypanosomiase humaine africaine. Bulletin of the World Health Organization 38, 1-8.
49. Mattern P, Pillot J & Bonnardot R (1965) Contribution à l'étude des immuno-globulines du liquide céphalo-rachidien responsables du phénomène d'immuno-fluorescence dans la neurosyphilis et dans la trypanosomiase nerveuse. Médecine d'Afrique Noire 6, 219-221.
50. Miézan TW, Meda HA, Doua F, Yapo FB & Baltz T (1998) Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebrospinal white cell count. Tropical Medicine and International Health 3, 571-575.
51. Miézan TW, Meda AH, Doua F et al. (2000) Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 293.
52. Miézan TW, Djé NN, Doua F & Boa F (2002) Trypanosomose humaine africaine en Côte d'Ivoire: caractéristiques biologiques après traitement. A propos de 812 cas traités dans le foyer de Daloa (Côte d'Ivoire). Bulletin de la Société de Pathologie Exotique et de ses Filiales 95, 362-365.
53. Moore A & Richer M (2001) Re-emergence of epidemic sleeping, sickness in southern Sudan. Tropical Medicine and International Health 6, 342-347.
54. Mott FW (1906) Histological observations on sleeping sickness and other trypanosome infections. Report of the Sleeping Sickness Commission of the Royal Society 7, 3-45.
55. Nantulya VM (1988) Immunodiagnosis of rhodesiense sleeping sickness: detection of circulating trypanosomal antigens in sera and cerebrospinal fluid by enzyme immunoassay using a monoclonal antibody. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 511-512.
56. Nantulya VM, Doua F & Molisho D (1992) Diagnosis of Trypanosoma brucei gambiense sleeping sickness using an antigen detection enzyme-linked immunosorbent assay. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 42-45.
57. Papadopoulos MC, Abel PM, Agranoff D et al. (2004) A novel and accurate diagnostic test for human African trypanosomiasis. The Lancet 363, 1358-1363.
58. 2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 795-799.
59. Pentreath VW, Owolabi AO & Doua F (1992) Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Annals of Tropical Medicine and Parasitology 86, 29-34.
60. Pentreath VW, Alafiatayo RA, Crawley B, Doua F & Oppenheim BA (1995) Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness. Parasitology 112, 67-73.
61. Pentreath VW, Alafiatayo RA, Barclay GR et al. (1997) Endotoxin antibodies in African sleeping sickness. Parasitology 114, 361-365.
62. Pépin J & Milord F (1991) African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 222-224.
63. Pépin J & Milord F (1994) The treatment of human African trypanosomiasis. Advances in Parasitology 33, 2-49.
64. Pépin J, Milord F, Khonde A et al. (1994) Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 447-452.
65. Roffi J, Dedet JP & Garre MT (1979) Diagnostic immunoenzymatique de la trypanosomiase en phase nerveuse par mise en évidence d'anticorps spécifiques dans le liquide céphalorachidien. Médecine et Maladies Infectieuses 9, 306-312.
66. Ruiz JA, Simarro PP & Josenando T (2002) Control of human African trypanosomiasis in the Quiçama focus, Angola. Bulletin of the World Health Organization 80, 738-745.
67. Schmid C, Nkunku S, Merolle A, Vounatsou P & Burri C (2004) Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. The Lancet 364, 789-790.
68. Scott D (1970) The epidemiology of Gambian Sleeping Sickness. In: The African Trypanosomiasis (ed. Mulligan HW) George Allen and Unwin Ltd, London, pp. 614-644.
69. Smith DH, Bailey JW & Wellde BT (1989) Immunodiagnostic tests on cerebrospinal fluid in the diagnosis of meningoencephalitic Trypanosoma brucei rhodesiense infection. Annals of Tropical Medicine and Parasitology 83, 91-97.
70. Stanghellini A & Josenando T (2001) The situation of sleeping sickness in Angola: a calamity. Tropical Medicine and International Health 6, 330-334.
71. True P, Jamonneau V, Cuny G & Frézil JL (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bulletin of the World Health Organization 77, 45-748.
72. Van Nieuwenhove S, Kande Betu-Ku-Mesu V, Mansinsa Diabakana P, Declercq J & Miaka Mia Bilenge C (2001) Sleeping sickness resurgence in the DRC: the past decade. Tropical Medicine and International Health 6, 335-341.
73. Van Meirvenne N (1999) Biological diagnosis of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds Dumas M, Bouteille B & Buguet A) Springer, Paris, pp. 235-252.
74. Van Nieuwenhove S (1999) Present strategies in the treatment of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds Dumas M, Bouteille B & Buguet A) Springer, Paris, pp. 253-281.
75. Whittle HC, Greenwood BM, Bidwell DE, Bartlett A & Voller A (1977) IgM and antibody measurement in the diagnosis and management of Gambian trypanosomiasis. American Journal of Tropical Medicine and Hygiene 26, 1129-1135.
76. WHO (1983) Trypanosomiasis Control Manual. African Medical and Research Foundation Nairobi, Kenya, Geneva, pp. 1-142.
77. WHO (1998) Control and surveillance of African trypanosomiasis. WHO Technical Report Series 881, 1-113.
78. Woo PTK (1971) Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. Acta Tropica 28, 298-303.